Want to join the conversation?
Drug company $PRGO reported higher 2Q16 results, helped by lower expenses in the quarter. $PRGO said net income rose 244.5% to $194.3MM, or $1.35 per share from $56.4MM, or $0.38 per share in the same quarter a year ago. Revenue fell 3.3% to $1.49Bil. Excluding items, $PRGO earned $1.93 per share, down 11% YoverY.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.